1986
DOI: 10.1111/j.1476-5381.1986.tb16260.x
|View full text |Cite
|
Sign up to set email alerts
|

Reversal by β‐funaltrexamine of the antinociceptive effect of opioid agonists in the rat

Abstract: 1 The effect of the irreversible opioid receptor antagonist, P-funaltrexamine (fi-FNA), on antinociception produced by p-and K-receptor agonists was studied in the rat.2 P-FNA, 20 to 80 mg kg-, s.c., given 24 h before testing, produced a dose-related antagonism of the effects ofmorphine in the paw pressure, hotplate and tail-flick tests. Following the 80 mg kg-' dose, the degree ofantagonism ofmorphine was stable for up to 48 h after dosing, but was reduced by 5 days and had disappeared by 8 days.3 In the paw … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
12
0

Year Published

1987
1987
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(14 citation statements)
references
References 19 publications
2
12
0
Order By: Relevance
“…question. The inhibitory effects of K-opioids, which were seen with high doses of tifluadom and Ekc (but never with U50488H), may have been the result of residual "-agonist activity (Hirning et al, 1985;Hayes et al, 1986). The suppressive actions of bremazocine appear to have been of a non-opioid nature.…”
Section: The Effects Ofopioid Agonistsmentioning
confidence: 97%
“…question. The inhibitory effects of K-opioids, which were seen with high doses of tifluadom and Ekc (but never with U50488H), may have been the result of residual "-agonist activity (Hirning et al, 1985;Hayes et al, 1986). The suppressive actions of bremazocine appear to have been of a non-opioid nature.…”
Section: The Effects Ofopioid Agonistsmentioning
confidence: 97%
“…The K-agonists U-50,488H and tifluadom Both of the K-opioids reduced responses to thermal noxious stimuli, on most cells at doses at the lower end of those used in behavioural tests of nociception (e.g. Romer et al, 1982a,b;Vonvoigtlander et al, 1983;Hayes et al, 1986;Leighton et al, 1988).…”
Section: The P-agonistfentanylmentioning
confidence: 99%
“…It is effective in preventing p-receptor activation by opioids in both in vitro bioassay systems (Ward et al, 1982a;Hayes et al, 1985;Corbett et al, 1985) and in vivo (Ward et al, 1982b;Hayes et al, 1986;Takemori & Portoghese, 1987). Ligand binding studies in brain homogenates suggest that this action is due to an irreversible reduction in the number of opioid binding sites (Rothman et al, 1983;Ward et al, 1985;Tam & Liu-Chen, 1986), possibly due to Michael addition with a thiol function close to the ligand-recognition site (Tam & Liu-Chen, 1986).…”
mentioning
confidence: 99%